{"transactions":[{"id":671937,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-08-31T12:00:21.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":13.79,"value":27580.0,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person may be deemed a control person of this entity."}],"balance_after":11005,"source":{"system":"sec-edgar","filing":"0001493152-26-040736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000149315226040736/ownership.xml","form_type":"4"}},{"id":677304,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":17096,"kind":"person","name":"BAGGER RICHARD H","position":1,"cik":"0001372907","reported_name":"BAGGER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2026-08-24T12:00:34.000Z","date":"2026-08-20","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":12.6,"value":12600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001999371-26-018494","document":"bagger-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126018494/bagger-form4.xml","form_type":"4"}},{"id":711804,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-07-09T13:05:31.000Z","date":"2026-06-30","kind":"other","planned":false,"acquired":true,"shares":1453,"price":10.914,"value":15858.042,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2025 Employee Stock Purchase Plan."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001493152-26-032615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000149315226032615/ownership.xml","form_type":"4"}},{"id":737983,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2026-06-15T11:00:12.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":1415,"price":10.55,"value":14928.25,"ownership":{"direct":true},"balance_after":1833,"source":{"system":"sec-edgar","filing":"0001493152-26-028608","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000149315226028608/ownership.xml","form_type":"4"}},{"id":744935,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2026-06-09T21:30:04.000Z","date":"2026-06-08","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":11.65,"value":58250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.63 to $11.65 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001493152-26-027985","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000149315226027985/ownership.xml","form_type":"4"}},{"id":744505,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-06-09T21:30:02.000Z","date":"2026-06-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":11.79,"value":58950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.735 to $11.883 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":9005,"source":{"system":"sec-edgar","filing":"0001493152-26-027986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000149315226027986/ownership.xml","form_type":"4"}},{"id":779450,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:48:35.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010754","document":"stillwell-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000199937126010754/stillwell-form4_051426.xml","form_type":"4"}},{"id":778891,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":21399,"kind":"person","name":"OLUKOTUN ADEOYE Y","position":1,"cik":"0001242615","reported_name":"OLUKOTUN ADEOYE Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:47:50.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010753","document":"olukotun-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126010753/olukotun-form4_051426.xml","form_type":"4"}},{"id":778890,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:47:02.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010752","document":"bell-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126010752/bell-form4_051426.xml","form_type":"4"}},{"id":779528,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47400,"kind":"person","name":"Hunter James Randolph Jr","position":1,"cik":"0002071788","reported_name":"Hunter James Randolph Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:46:19.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010751","document":"hunter-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2071788/000199937126010751/hunter-form4_051426.xml","form_type":"4"}},{"id":778889,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:45:40.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010750","document":"treco-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126010750/treco-form4_051426.xml","form_type":"4"}},{"id":778888,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47304,"kind":"person","name":"GRANGE DAVID L","position":1,"cik":"0001264908","reported_name":"GRANGE DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:43:40.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010749","document":"grange-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126010749/grange-form4_051426.xml","form_type":"4"}},{"id":778887,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":17096,"kind":"person","name":"BAGGER RICHARD H","position":1,"cik":"0001372907","reported_name":"BAGGER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:42:43.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010748","document":"bagger-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126010748/bagger-form4_051426.xml","form_type":"4"}},{"id":779394,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-14T21:41:51.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2026 Stock Incentive Plan, and vests on the earlier of the one year anniversary of the grant date and the Issuer's 2027 Annual Meeting of Stockholders."}],"balance_after":22700,"derivative":{"exercise_price":13.28,"exercise_date":"2027-05-12","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001999371-26-010747","document":"taylor-form4_051426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000199937126010747/taylor-form4_051426.xml","form_type":"4"}},{"id":822763,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-04-01T13:31:21.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":12.62,"value":63100.0,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $12.5699 to $12.625 per share. The Reporting Persons undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting person may be deemed a control person of this entity."}],"balance_after":20001,"source":{"system":"sec-edgar","filing":"0001999371-26-007447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007447/ownership.xml","form_type":"4"}},{"id":834812,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-03-18T21:03:27.000Z","date":"2026-03-18","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":14.89,"value":223350.0,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person may be deemed a control person of this entity."}],"balance_after":15001,"source":{"system":"sec-edgar","filing":"0001999371-26-006235","document":"form4-lederman_031826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126006235/form4-lederman_031826.xml","form_type":"4"}},{"id":879448,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:03:32.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39011,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39011},"source":{"system":"sec-edgar","filing":"0001999371-26-004389","document":"morris-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004389/morris-form4_022626.xml","form_type":"4"}},{"id":879447,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:03:32.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39012,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39012},"source":{"system":"sec-edgar","filing":"0001999371-26-004389","document":"morris-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004389/morris-form4_022626.xml","form_type":"4"}},{"id":879644,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:03:05.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39011,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39011},"source":{"system":"sec-edgar","filing":"0001999371-26-004388","document":"saenger-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937126004388/saenger-form4_022626.xml","form_type":"4"}},{"id":879643,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:03:05.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39012,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39012},"source":{"system":"sec-edgar","filing":"0001999371-26-004388","document":"saenger-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937126004388/saenger-form4_022626.xml","form_type":"4"}},{"id":879446,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:01:33.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":134503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":134503,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":134503},"source":{"system":"sec-edgar","filing":"0001999371-26-004385","document":"lederman-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004385/lederman-form4_022626.xml","form_type":"4"}},{"id":879445,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:01:33.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":134504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":134504,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":134504},"source":{"system":"sec-edgar","filing":"0001999371-26-004385","document":"lederman-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004385/lederman-form4_022626.xml","form_type":"4"}},{"id":879586,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-26T07:02:37.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39011,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39011},"source":{"system":"sec-edgar","filing":"0001999371-26-004387","document":"sullivan-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000199937126004387/sullivan-form4_022626.xml","form_type":"4"}},{"id":879585,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-26T07:02:37.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39012,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39012},"source":{"system":"sec-edgar","filing":"0001999371-26-004387","document":"sullivan-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000199937126004387/sullivan-form4_022626.xml","form_type":"4"}},{"id":880046,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64526,"kind":"person","name":"Fogarty Siobhan","position":1,"cik":"0002055825","reported_name":"Fogarty Siobhan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option","published_at":"2026-02-26T07:02:06.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39011,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39011},"source":{"system":"sec-edgar","filing":"0001999371-26-004386","document":"fogarty-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2055825/000199937126004386/fogarty-form4_022626.xml","form_type":"4"}},{"id":880045,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64526,"kind":"person","name":"Fogarty Siobhan","position":1,"cik":"0002055825","reported_name":"Fogarty Siobhan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option","published_at":"2026-02-26T07:02:06.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39012,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39012},"source":{"system":"sec-edgar","filing":"0001999371-26-004386","document":"fogarty-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2055825/000199937126004386/fogarty-form4_022626.xml","form_type":"4"}},{"id":901000,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2026-02-17T12:00:19.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":701,"price":13.42,"value":9407.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2025 Employee Stock Purchase Plan."}],"balance_after":701,"source":{"system":"sec-edgar","filing":"0001999371-26-003371","document":"saenger-form5_021626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937126003371/saenger-form5_021626.xml","form_type":"5"}},{"id":1059375,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-08-21T21:22:56.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":418,"price":36.03,"value":15060.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. Actual purchase prices ranged from $35.98 to $36.05."}],"balance_after":418,"source":{"system":"sec-edgar","filing":"0001999371-25-011836","document":"taylor-form4_082125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000199937125011836/taylor-form4_082125.xml","form_type":"4"}},{"id":1060142,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-08-20T20:15:15.000Z","date":"2025-08-20","kind":"purchase","planned":false,"acquired":true,"shares":250,"price":36,"value":9000.0,"ownership":{"direct":true},"balance_after":250,"source":{"system":"sec-edgar","filing":"0001999371-25-011754","document":"treco-form4_082025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125011754/treco-form4_082025.xml","form_type":"4"}},{"id":1112162,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47400,"kind":"person","name":"Hunter James Randolph Jr","position":1,"cik":"0002071788","reported_name":"Hunter James Randolph Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-13T20:42:46.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":7740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the date of the Company's 2026 annual meeting of stockholders."}],"balance_after":7740,"derivative":{"exercise_price":34.54,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":7740},"source":{"system":"sec-edgar","filing":"0001999371-25-007769","document":"hunter-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2071788/000199937125007769/hunter-form4.xml","form_type":"4"}},{"id":1147252,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-05-15T21:08:40.000Z","date":"2025-05-15","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":21.55,"value":86200.0,"ownership":{"direct":true},"balance_after":4005,"source":{"system":"sec-edgar","filing":"0001999371-25-006261","document":"lederman-ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006261/lederman-ownership.xml","form_type":"4"}},{"id":1147251,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T21:04:29.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006255","document":"treco-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006255/treco-form4.xml","form_type":"4"}},{"id":1147250,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T21:00:55.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006253","document":"bell-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006253/bell-form4.xml","form_type":"4"}},{"id":1147651,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T20:57:11.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006250","document":"taylor-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000199937125006250/taylor-form4.xml","form_type":"4"}},{"id":1147249,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":17096,"kind":"person","name":"BAGGER RICHARD H","position":1,"cik":"0001372907","reported_name":"BAGGER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T20:54:29.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006248","document":"bagger-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006248/bagger-form4.xml","form_type":"4"}},{"id":1147701,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T20:51:59.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006245","document":"stillwell-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000199937125006245/stillwell-form4.xml","form_type":"4"}},{"id":1147248,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":21399,"kind":"person","name":"OLUKOTUN ADEOYE Y","position":1,"cik":"0001242615","reported_name":"OLUKOTUN ADEOYE Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T20:49:44.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006242","document":"olukotun-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006242/olukotun-form4.xml","form_type":"4"}},{"id":1147247,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47304,"kind":"person","name":"GRANGE DAVID L","position":1,"cik":"0001264908","reported_name":"GRANGE DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-05-15T20:47:52.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended, and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2026 Annual Meeting of Stockholders."}],"balance_after":10000,"derivative":{"exercise_price":20.18,"exercise_date":"2026-05-13","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001999371-25-006236","document":"grange-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006236/grange-form4.xml","form_type":"4"}},{"id":1238302,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-28T22:32:22.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":1,"price":0.15,"value":0.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-012474","document":"bell-form4_022825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225012474/bell-form4_022825.xml","form_type":"4"}},{"id":1238301,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-28T22:31:48.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.02,"price":0.3,"value":0.006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-012472","document":"treco-form4_022825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225012472/treco-form4_022825.xml","form_type":"4"}},{"id":1238300,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":21399,"kind":"person","name":"OLUKOTUN ADEOYE Y","position":1,"cik":"0001242615","reported_name":"OLUKOTUN ADEOYE Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-28T22:31:25.000Z","date":"2024-06-10","kind":"other","planned":false,"acquired":false,"shares":0.812,"price":1.91,"value":1.55092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-012471","document":"olukotun-form4_022825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225012471/olukotun-form4_022825.xml","form_type":"4"}},{"id":1238297,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":17096,"kind":"person","name":"BAGGER RICHARD H","position":1,"cik":"0001372907","reported_name":"BAGGER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-28T22:30:50.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.02,"price":0.2,"value":0.004,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Involuntary sale of fractional shares following a reverse stock split of the Issuer's comment stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-012470","document":"bagger-form4_022825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225012470/bagger-form4_022825.xml","form_type":"4"}},{"id":1240707,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:51:04.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":25792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":25792,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":25792},"source":{"system":"sec-edgar","filing":"0001839882-25-011958","document":"saenger-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988225011958/saenger-form4_022725.xml","form_type":"4"}},{"id":1240706,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:51:04.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":25792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":25792,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":25792},"source":{"system":"sec-edgar","filing":"0001839882-25-011958","document":"saenger-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988225011958/saenger-form4_022725.xml","form_type":"4"}},{"id":1240705,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-27T23:51:04.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.04,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were surrendered without considerations following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-011958","document":"saenger-form4_022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988225011958/saenger-form4_022725.xml","form_type":"4"}},{"id":1240530,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":123958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":123958,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":123958},"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240529,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":123958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":123958,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":123958},"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240528,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":1,"price":0.15,"value":0.15,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Involuntary sale of fractional share following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240527,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.22,"price":3.3,"value":0.726,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Involuntary sale of fractional share following a reverse stock split of the Issuer's common stock."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240526,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":5.18,"price":3.38,"value":17.5084,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Involuntary sale of fractional share following a reverse stock split of the Issuer's common stock."}],"balance_after":5,"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240533,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:44:51.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":29291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":29291,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":29291},"source":{"system":"sec-edgar","filing":"0001839882-25-011949","document":"morris_form4-022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011949/morris_form4-022725.xml","form_type":"4"}},{"id":1240532,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:44:51.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":29291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":29291,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":29291},"source":{"system":"sec-edgar","filing":"0001839882-25-011949","document":"morris_form4-022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011949/morris_form4-022725.xml","form_type":"4"}},{"id":1240531,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-27T23:44:51.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were surrendered without considerations following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-011949","document":"morris_form4-022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011949/morris_form4-022725.xml","form_type":"4"}},{"id":1240649,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-02-27T18:49:35.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":29017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":29017,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":29017},"source":{"system":"sec-edgar","filing":"0001839882-25-011955","document":"sullivan_form4-022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988225011955/sullivan_form4-022725.xml","form_type":"4"}},{"id":1240648,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-02-27T18:49:35.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":29017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":29017,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":29017},"source":{"system":"sec-edgar","filing":"0001839882-25-011955","document":"sullivan_form4-022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988225011955/sullivan_form4-022725.xml","form_type":"4"}},{"id":1240647,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-27T18:49:35.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.11,"price":1.47,"value":0.1617,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-011955","document":"sullivan_form4-022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988225011955/sullivan_form4-022725.xml","form_type":"4"}},{"id":1241208,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64526,"kind":"person","name":"Fogarty Siobhan","position":1,"cik":"0002055825","reported_name":"Fogarty Siobhan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option","published_at":"2025-02-27T18:42:45.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":13500,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001839882-25-011945","document":"fogarty-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2055825/000183988225011945/fogarty-form4_022725.xml","form_type":"4"}},{"id":1241207,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64526,"kind":"person","name":"Fogarty Siobhan","position":1,"cik":"0002055825","reported_name":"Fogarty Siobhan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option","published_at":"2025-02-27T18:42:45.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":13500,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001839882-25-011945","document":"fogarty-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2055825/000183988225011945/fogarty-form4_022725.xml","form_type":"4"}},{"id":1501833,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:10:58.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006625","document":"treco-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124006625/treco-form4.xml","form_type":"4"}},{"id":1502216,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:10:36.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006624","document":"taylor-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000199937124006624/taylor-form4.xml","form_type":"4"}},{"id":1502251,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:07:45.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006623","document":"stillwell-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000199937124006623/stillwell-form4.xml","form_type":"4"}},{"id":1501832,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":21399,"kind":"person","name":"OLUKOTUN ADEOYE Y","position":1,"cik":"0001242615","reported_name":"OLUKOTUN ADEOYE Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:07:07.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006622","document":"olukotun-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124006622/olukotun-form4.xml","form_type":"4"}},{"id":1501831,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47304,"kind":"person","name":"GRANGE DAVID L","position":1,"cik":"0001264908","reported_name":"GRANGE DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:06:26.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006620","document":"grange-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124006620/grange-form4.xml","form_type":"4"}},{"id":1501830,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:05:04.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006618","document":"bell-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124006618/bell-form4.xml","form_type":"4"}},{"id":1501829,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":17096,"kind":"person","name":"BAGGER RICHARD H","position":1,"cik":"0001372907","reported_name":"BAGGER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-24T21:04:23.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":104621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":104621,"derivative":{"exercise_price":0.1745,"exercise_date":"2025-05-23","expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":104621},"source":{"system":"sec-edgar","filing":"0001999371-24-006617","document":"bagger-form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124006617/bagger-form4.xml","form_type":"4"}},{"id":1591446,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-03-06T22:01:16.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1309911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The amendment corrects the Conversion or Exercise Price of from $0.0368 to $0.368."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":1309911,"derivative":{"exercise_price":0.368,"exercise_date":"2024-08-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":1309911},"source":{"system":"sec-edgar","filing":"0001999371-24-003168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124003168/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-29"}},{"id":1591445,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-03-06T22:01:16.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1903680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":1903680,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":1903680},"source":{"system":"sec-edgar","filing":"0001999371-24-003168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124003168/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-29"}},{"id":1591444,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-03-06T22:01:16.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":235320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":235320,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":235320},"source":{"system":"sec-edgar","filing":"0001999371-24-003168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124003168/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-29"}},{"id":1609854,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:08:09.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1309911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":1309911,"derivative":{"exercise_price":0.0368,"exercise_date":"2024-08-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":1309911},"source":{"system":"sec-edgar","filing":"0001999371-24-002952","document":"lederman-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002952/lederman-form4_022724.xml","form_type":"4"}},{"id":1609853,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:08:09.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1903680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":1903680,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":1903680},"source":{"system":"sec-edgar","filing":"0001999371-24-002952","document":"lederman-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002952/lederman-form4_022724.xml","form_type":"4"}},{"id":1609852,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:08:09.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":235320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":235320,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":235320},"source":{"system":"sec-edgar","filing":"0001999371-24-002952","document":"lederman-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002952/lederman-form4_022724.xml","form_type":"4"}},{"id":1610026,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:07:19.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":282000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":282000,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":282000},"source":{"system":"sec-edgar","filing":"0001999371-24-002951","document":"saenger-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937124002951/saenger-form4_022724.xml","form_type":"4"}},{"id":1610025,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:07:19.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":282000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":282000,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":282000},"source":{"system":"sec-edgar","filing":"0001999371-24-002951","document":"saenger-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000199937124002951/saenger-form4_022724.xml","form_type":"4"}},{"id":1609851,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:06:23.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":317000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":317000,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":317000},"source":{"system":"sec-edgar","filing":"0001999371-24-002950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002950/ownership.xml","form_type":"4"}},{"id":1609850,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:06:23.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":317000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":317000,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":317000},"source":{"system":"sec-edgar","filing":"0001999371-24-002950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002950/ownership.xml","form_type":"4"}},{"id":1609974,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2024-02-29T17:05:49.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":358000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":358000,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":358000},"source":{"system":"sec-edgar","filing":"0001999371-24-002949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000199937124002949/ownership.xml","form_type":"4"}},{"id":1609973,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2024-02-29T17:05:49.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":358000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":358000,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":358000},"source":{"system":"sec-edgar","filing":"0001999371-24-002949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000199937124002949/ownership.xml","form_type":"4"}},{"id":1898036,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":17096,"kind":"person","name":"BAGGER RICHARD H","position":1,"cik":"0001372907","reported_name":"BAGGER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:15:05.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223012505/ownership.xml","form_type":"4"}},{"id":1898035,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:14:39.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223012504/ownership.xml","form_type":"4"}},{"id":1898034,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47304,"kind":"person","name":"GRANGE DAVID L","position":1,"cik":"0001264908","reported_name":"GRANGE DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:13:49.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223012503/ownership.xml","form_type":"4"}},{"id":1898033,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":21399,"kind":"person","name":"OLUKOTUN ADEOYE Y","position":1,"cik":"0001242615","reported_name":"OLUKOTUN ADEOYE Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:11:55.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223012502/ownership.xml","form_type":"4"}},{"id":1898338,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:09:49.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012501","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000183988223012501/ownership.xml","form_type":"4"}},{"id":1898316,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:08:34.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001839882-23-012500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000183988223012500/ownership.xml","form_type":"4"}},{"id":1898032,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-05-10T21:01:11.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023."}],"balance_after":60000,"derivative":{"exercise_price":0.509,"exercise_date":"2024-05-08","expiration_date":"2033-05-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001387131-23-006320","document":"treco-form4_050823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713123006320/treco-form4_050823.xml","form_type":"4"}},{"id":1950312,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":40123,"kind":"person","name":"Stillwell Richard Newcomb","position":1,"cik":"0001966861","reported_name":"Stillwell Richard Newcomb","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-03-16T23:43:34.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests on the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":83000,"derivative":{"exercise_price":0.562,"expiration_date":"2033-03-15","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0001839882-23-006928","document":"stillwell-form4_031523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966861/000183988223006928/stillwell-form4_031523.xml","form_type":"4"}},{"id":1993235,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:37:39.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":200000,"derivative":{"exercise_price":0.914,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001839882-23-004703","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988223004703/ownership.xml","form_type":"4"}},{"id":1993234,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":31208,"kind":"person","name":"SAENGER BRADLEY","position":1,"cik":"0001668150","reported_name":"SAENGER BRADLEY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:37:39.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":200000,"derivative":{"exercise_price":0.731,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001839882-23-004703","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668150/000183988223004703/ownership.xml","form_type":"4"}},{"id":1992992,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:36:51.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":207500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":207500,"derivative":{"exercise_price":0.914,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":207500},"source":{"system":"sec-edgar","filing":"0001839882-23-004702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223004702/ownership.xml","form_type":"4"}},{"id":1992991,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:36:51.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":207500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":207500,"derivative":{"exercise_price":0.731,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":207500},"source":{"system":"sec-edgar","filing":"0001839882-23-004702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223004702/ownership.xml","form_type":"4"}},{"id":1992990,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:34:28.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":700000,"derivative":{"exercise_price":0.914,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001839882-23-004701","document":"lederman-form4_022322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223004701/lederman-form4_022322.xml","form_type":"4"}},{"id":1992989,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:34:28.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":700000,"derivative":{"exercise_price":0.731,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001839882-23-004701","document":"lederman-form4_022322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223004701/lederman-form4_022322.xml","form_type":"4"}},{"id":1993166,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2023-02-24T18:38:05.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":220000,"derivative":{"exercise_price":0.914,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001839882-23-004704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988223004704/ownership.xml","form_type":"4"}},{"id":1993165,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2023-02-24T18:38:05.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":220000,"derivative":{"exercise_price":0.731,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001839882-23-004704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988223004704/ownership.xml","form_type":"4"}},{"id":2217148,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2022-07-01T20:05:23.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":20000,"price":1.71,"value":34200.0,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares reported reflect a 1-for-32 reverse stock split effective May 17, 2022."}],"balance_after":24235,"source":{"system":"sec-edgar","filing":"0001387131-22-007441","document":"lederman-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122007441/lederman-form4.xml","form_type":"4"}},{"id":2274984,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":38223,"kind":"person","name":"Taylor Carolyn E.","position":1,"cik":"0001875324","reported_name":"Taylor Carolyn E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:49:47.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875324/000138713122006019/ownership.xml","form_type":"4"}},{"id":2274658,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":17096,"kind":"person","name":"BAGGER RICHARD H","position":1,"cik":"0001372907","reported_name":"BAGGER RICHARD H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:46:31.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122006018/ownership.xml","form_type":"4"}},{"id":2274669,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47306,"kind":"person","name":"Bell Margaret Smith","position":1,"cik":"0001716713","reported_name":"Bell Margaret Smith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:44:06.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122006017/ownership.xml","form_type":"4"}},{"id":2274656,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47304,"kind":"person","name":"GRANGE DAVID L","position":1,"cik":"0001264908","reported_name":"GRANGE DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:42:37.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122006016/ownership.xml","form_type":"4"}},{"id":2274655,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":21399,"kind":"person","name":"OLUKOTUN ADEOYE Y","position":1,"cik":"0001242615","reported_name":"OLUKOTUN ADEOYE Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:40:27.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122006015/ownership.xml","form_type":"4"}},{"id":2274654,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":47305,"kind":"person","name":"Treco James","position":1,"cik":"0001766070","reported_name":"Treco James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-11T21:38:45.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2131500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":2131500,"derivative":{"exercise_price":0.132,"exercise_date":"2023-05-09","expiration_date":"2032-05-09","underlying":"Common Stock","underlying_shares":2131500},"source":{"system":"sec-edgar","filing":"0001387131-22-006014","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122006014/ownership.xml","form_type":"4"}}],"next_cursor":"2022-05-11T21:38:45.000000Z,2274654"}